Evelina Vågesjö
Directeur/Membre du Conseil chez LYTIX BIOPHARMA
Profil
Evelina Wanda Matilda Vågesjö is the founder and current Chief Executive Officer of Ilya Pharma AB, which is founded in 2016.
She is also currently working as a Director at Lytix Biopharma.
AS since 2021.
Dr. Vågesjö holds a doctorate from the University of Uppsala and an MBA from Heriot-Watt University.
Postes actifs de Evelina Vågesjö
| Sociétés | Poste | Début |
|---|---|---|
| LYTIX BIOPHARMA | Directeur/Membre du Conseil | 07/06/2021 |
Ilya Pharma AB
 Ilya Pharma AB BiotechnologyHealth Technology Ilya Pharma AB develops biological drugs for treating wounds in skin and mucosa. The company was incorporated in May 13, 2016 by Mia Johanna Phillipson, Stefan Roos and Evelina Wanda Matilda Vågesjö and is headquartered in Uppsala, Sweden. | Directeur Général | 13/05/2016 |
Formation de Evelina Vågesjö
| University of Uppsala | Doctorate Degree |
| Heriot-Watt University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ilya Pharma AB
Ilya Pharma AB BiotechnologyHealth Technology Ilya Pharma AB develops biological drugs for treating wounds in skin and mucosa. The company was incorporated in May 13, 2016 by Mia Johanna Phillipson, Stefan Roos and Evelina Wanda Matilda Vågesjö and is headquartered in Uppsala, Sweden. | Health Technology |
